Myosin 9 Antikörper (AA 131-220)
-
- Target Alle Myosin 9 (MYH9) Antikörper anzeigen
- Myosin 9 (MYH9)
-
Bindungsspezifität
- AA 131-220
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Myosin 9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant MYH9.
- Sequenz
- RLKQLKRQLE EAEEEAQRAN ASRRKLQREL EDATETADAM NREVSSLKNK LRRGDLPFVV PRRMARKGAG DGSDEEVDGK ADGAEAKPAE
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- MYH9 (NP_002464.1, 1871 a.a. ~ 1960 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 4H3
- Isotyp
- IgG2b
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells." in: Molecular oncology, Vol. 6, Issue 3, pp. 299-310, (2012) (PubMed).
: "A proteomic study of myosin II motor proteins during tumor cell migration." in: Journal of molecular biology, Vol. 407, Issue 5, pp. 673-86, (2011) (PubMed).
: "
-
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells." in: Molecular oncology, Vol. 6, Issue 3, pp. 299-310, (2012) (PubMed).
-
- Target
- Myosin 9 (MYH9)
- Andere Bezeichnung
- MYH9 (MYH9 Produkte)
- Hintergrund
-
Full Gene Name: myosin, heavy chain 9, non-muscle
Synonyms: DFNA17,EPSTS,FTNS,MGC104539,MHA,NMHC-II-A,NMMHCA - Gen-ID
- 4627
- NCBI Accession
- NM_002473
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex
-